-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GF6LSHy59+SS9+9rRaeEVZm6r63Db5AQgw5QIo4E8wCvTWylsweObGl2uknHmY8L NaSoXlDeeA4Gm+Mx3UQ47A== 0000950130-96-000285.txt : 19960131 0000950130-96-000285.hdr.sgml : 19960131 ACCESSION NUMBER: 0000950130-96-000285 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960129 SROS: NASD GROUP MEMBERS: ROBERT A. VUKOVICH GROUP MEMBERS: ROBERTS PHARMACEUTICAL CORP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40691 FILM NUMBER: 96508136 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 908-389-11 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 908-389-11 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 SC 13G/A 1 AMENDMENT NO. 6 TO SCHEDULE 13G ----------------------------- | OMB APPROVAL | |---------------------------- |OMB Number: 3235-0145 | |Expires: December 31, 1997 | |Estimated average burden | |hours per response....14.90| ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* ---------- ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class Securities) 770491-10-8 -------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this coverage page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages CUSIP NO. 770491-10-8 13G Page 2 of 5 Pages 1. NAME OF REPORTING PERSON S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Robert A. Vukovich Social Security No. ###-##-#### - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - ------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 1,887,571 -------------------------------------------------------- 6. SHARED VOTING POWER 0 -------------------------------------------------------- 7. SOLE DISPOSITIVE POWER 1,887,571 -------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,887,571 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 1,887,571 - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 5 pages SCHEDULE 13G (continued) Item 1. (a) Name of Issuer: Roberts Pharmaceutical Corporation (b) Address of Issuer's Principal Executive Offices: Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 Item 2. (a) Name of Person Filing: Robert A. Vukovich (b) Address of Principal Office or, if none, Residence: Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 (c) Citizenship: U.S.A. (d) Title of Class of Securities Common Stock, $.01 par value (e) CUSIP Number: 770491-10-8 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: Not Applicable. Item 4. Ownership (as of December 31, 1995) (a) Amount Beneficially Owned: 1,887,571 (b) Percent of Class: 8.7% Page 3 of 5 (c) Number of Shares as to which such person has: (i) sole power to vote or to direct the vote of 1,887,571 --------- shares including 250,000 shares subject to a currently ------- exercisable option. (ii) shared power to vote or to direct the vote of 0 --- shares. (iii) sole power to dispose or to direct the disposition of 1,887,571 shares including 250,000 shares subject to a --------- ------- currently exercisable option. (iv) shared power to dispose of or to direct the disposition of 0 shares. --- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not Applicable ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable Page 4 of 5 ITEM 10. CERTIFICATION After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 29, 1996 /s/ Robert A. Vukovich - ----------------------- Signature Robert A. Vukovich Chairman of the Board and President - ------------------------- Name/Title Page 5 of 5 -----END PRIVACY-ENHANCED MESSAGE-----